SRY-box transcription factor 2–DNA complex at the type I collagen promoter (SOX2–DNA (COL1A1/COL1A2))

The SRY-box transcription factor 2 (SOX2)–DNA complex at the type I collagen promoter is a specific molecular assembly where the SOX2 protein binds to regulatory sequences of the COL1A1 or COL1A2 genes. SOX2 is a critical transcription factor that maintains the undifferentiated state of stem cells and governs various developmental processes [1]. In the context of collagen regulation, SOX2 often acts as a transcriptional repressor, particularly in osteoblasts and mesenchymal lineages, thereby controlling the density and composition of the extracellular matrix [2]. This complex is a significant focal point in the study of fibrotic diseases, such as systemic sclerosis, where the loss of SOX2-mediated repression can lead to excessive collagen deposition [3][4]. Furthermore, in various cancers, SOX2 can modulate the tumor microenvironment by altering collagen expression, which in turn influences epithelial-mesenchymal transition (EMT) and metastatic potential [5]. While direct pharmacological targeting of this specific complex is currently experimental, strategies include the use of small molecules like Mithramycin A that interfere with transcription factor-DNA binding [6]. Therapeutic intervention aims to restore normal collagen expression levels, though challenges exist regarding the specificity of such treatments and the potential for adverse effects on SOX2's vital roles in other tissues [7].

Other names

SOX2-COL1A1 promoter complexSOX2-COL1A2 promoter complexSOX2-DNA interaction at the collagen type I locusSRY-box 2 binding site at the type I collagen promoter

Modulation of collagen gene transcription by interfering with the binding of SOX2 to its cognate DNA sequence within the type I collagen promoter.